From: Richard Geggie [rgeggie@monitor.net] Sent: Thursday, March 29, 2001 11:27 PM To: fdadockets@oc.fda.gov Subject: genetically modified foods I strongly protest what is happening, or better, what is not happening to protect my health and the health of my grandchildren. I know you will do what you can to resist influence by corporations blind to the impact of what they are doing. The following list is shameful and persons party to any of it will someday be held very responsible for participating in such disrespectful, dangerous, and sad madness. Present FDA policy * Does not require mandatory pre-market safety testing * Does not require pre-market environmental review * Does not require mandatory labeling of GE foods * Restricts voluntary labeling of non-GE foods * Requires a mere letter of notification prior to the marketing of a GE food * Fails to ensure public access to adequate information for independent review * Is supported by industry and opposed by consumer groups. The FDA is supposed to protect all people, not industry people. I want the following: * The FDA must require mandatory pre-market comprehensive environmental review. Unlike conventional pollutants, where a given amount of pollutant causes a limited amount of damage, a small number of mutant genes could have a population explosion and reproduce forever, causing unlimited and irreparable damage. * The FDA must require mandatory pre-market long-term health testing. GE products could be toxic, cause allergic responses, have lower nutritional value, and compromise immune responses in consumers. * The FDA must require mandatory labeling of GE products. Without mandatory labeling, neither consumers nor health professionals will know if an allergic or toxic reaction was the result of a genetically engineered food. Consumers would be deprived of the critical knowledge needed to hold food producers liable should any of these novel products be hazardous. * The FDA must end its cozy relationship with the industries it purports to be regulating. People have been allowed to work for a biotech company, then work for the FDA writing the regulatory rules on that company's product, then go back to working for the company. Ninety-two percent of FDA advisory committee meetings had at least one conflict of interest. Enough is enough. Richard Geggie